On a molecular level, HSCs were shown to be activated by TGF-β, which is secreted by cancer cells [21,22,23,24] and was found to be overexpressed in CCA stroma and to correlate with poor prognosis [25]. Here, TGFB1 is linked to cholangiocarcinoma.